Abstract

A series of sixteen N-(trans)-3-phenylprop-2-en-1-yl (cinnamyl) derivatives of various aminoalkanols was synthesized and evaluated for anticonvulsant activity and neurotoxicity. In preliminary evaluation three standard tests in mice after intraperitoneal administration were used: maximal electroshock (MES), subcutaneous pentetrazol, and rotarod test. Fifteen compounds showed some protection in MES. Next step included evaluation in rats after oral administration. The most promising compound, (R,S)-2-{[(trans)-3-phenylprop-2-en-1-yl]amino}propan-1-ol hydrochloride (1a), was also tested in model of pilocarpine-induced status prevention, 6-Hz test, and in vitro neuroprotection evaluation. Additionally, for selected compounds experimental pK_a values were determined as well as serotonin receptors (5-HT_1A, 5-HT₆, and 5- HT₇) binding affinities were found. None of the tested compounds showed significant binding affinity to serotonin receptors. However, in vivo pharmacological results indicated that further modification of the structures might lead to discovering new potential anticonvulsants.

Keywords: Aminoalkanols, Anticonvulsant, Cinnamyl, Epilepsy, Maximal electroshock, Pentetrazol.

Graphical Abstract